Novel plasma metabolite markers of attention-deficit/hyperactivity disorder identified using high-performance chemical isotope labelling-based liquid chromatography-mass spectrometry

References

• Albrecht P, Lewerenz J, Dittmer S, Noack R, Maher P, Methner A. 2010. Mechanisms of oxidative glutamate toxicity: the glutamate/cystine antiporter system xc- as a neuroprotective drug target. CNS Neurol Disord Drug Targets. 9(3):373–382.
   PubMed Web of Science ®Google Scholar
• Altinoz MA, Ozpinar A. 2019. Acetylsalicylic acid and its metabolite gentisic acid may act as adjunctive agents in the treatment of psychiatric disorders. Behav Pharmacol. 30(8):627–641.
   PubMed Web of Science ®Google Scholar
• Bonvicini C, Faraone SV, Scassellati C. 2016. Attention-deficit hyperactivity disorder in adults: a systematic review and meta-analysis of genetic, pharmacogenetic and biochemical studies. Mol Psychiatry. 21(7):872–884.
   PubMed Web of Science ®Google Scholar
• Bonvicini C, Faraone SV, Scassellati C. 2018. Common and specific genes and peripheral biomarkers in children and adults with attention-deficit/hyperactivity disorder. World J Biol Psychiatry. 19(2):80–100.
   PubMed Web of Science ®Google Scholar
• Bostwick JR, Landers DW, Crawford G, Lau K, Appel SH. 1989. Purification and characterization of a central cholinergic enhancing factor from rat brain: its identity as phosphoethanolamine. J Neurochem. 53(2):448–458.
   PubMed Web of Science ®Google Scholar
• Bylesjo M, Rantalainen M, Cloarec O, Nicholson JK, Holmes E, Trygg J. 2006. OPLS discriminant analysis: combining the strengths of PLS-DA and SIMCA classification. J Chemometrics. 20(8–10):341–351.
   Web of Science ®Google Scholar
• Chen T, Yuan H, Sun YB, Song YC, Lu M, Ni X, Han X. 2019. Metabolomics study of the prefrontal cortex in a rat model of attention deficit hyperactivity disorder reveals the association between cholesterol metabolism disorder and hyperactive behavior. Biochem Biophys Res Commun. 523(2):315–321.
   PubMed Web of Science ®Google Scholar
• Dimatelis JJ, Hsieh JH, Sterley TL, Marais L, Womersley JS, Vlok M, Russell VA. 2015. Impaired energy metabolism and disturbed dopamine and glutamate signalling in the striatum and prefrontal cortex of the spontaneously hypertensive rat model of attention-deficit hyperactivity disorder. J Mol Neurosci. 56(3):696–707.
   PubMed Web of Science ®Google Scholar
• Eriksson L, Trygg J, Wold S. 2008. CV-ANOVA for significance testing of PLS and OPLS (R) models. J Chemometrics. 22(11–12):594–600.
   Web of Science ®Google Scholar
• Gau SS, Lin CH, Hu FC, Shang CY, Swanson JM, Liu YC, Liu SK. 2009. Psychometric properties of the Chinese version of the Swanson, Nolan, and Pelham, Version IV Scale-Teacher Form. J Pediatr Psychol. 34(8):850–861.
   PubMed Web of Science ®Google Scholar
• Gau SS, Shang CY, Liu SK, Lin CH, Swanson JM, Liu YC, Tu CL. 2008. Psychometric properties of the Chinese version of the Swanson, Nolan, and Pelham, version IV scale – parent form. Int J Methods Psychiatr Res. 17(1):35–44.
   PubMed Web of Science ®Google Scholar
• Gong R, Ding C, Hu J, Lu Y, Liu F, Mann E, Xu F, Cohen MB, Luo M. 2011. Role for the membrane receptor guanylyl cyclase-C in attention deficiency and hyperactive behavior. Science. 333(6049):1642–1646.
   PubMed Web of Science ®Google Scholar
• Guo K, Bamforth F, Li L. 2011. Qualitative metabolome analysis of human cerebrospinal fluid by 13C-/12C-isotope dansylation labeling combined with liquid chromatography Fourier transform ion cyclotron resonance mass spectrometry. J Am Soc Mass Spectrom. 22(2):339–347.
   PubMed Web of Science ®Google Scholar
• Guo K, Li L. 2009. Differential 12C-/13C-isotope dansylation labeling and fast liquid chromatography/mass spectrometry for absolute and relative quantification of the metabolome. Anal Chem. 81(10):3919–3932.
   PubMed Web of Science ®Google Scholar
• Hagiwara D, Miyake H, Morimoto H, Murai M, Fujii T, Matsuo M. 1992. Studies on neurokinin antagonists. 2. Design and structure-activity relationships of novel tripeptide substance P antagonists, N alpha-[N alpha-(N alpha-acetyl-L-threonyl)-N1-formyl-D-tryptophyl]-N- methyl-N-(phenylmethyl)-L-phenylalaninamide and its related compounds. J Med Chem. 35(17):3184–3191.
   PubMed Web of Science ®Google Scholar
• Hsu CW, Chen YT, Hsieh YJ, Chang KP, Hsueh PC, Chen TW, Yu JS, Chang YS, Li L, Wu CC. 2019. Integrated analyses utilizing metabolomics and transcriptomics reveal perturbation of the polyamine pathway in oral cavity squamous cell carcinoma. Anal Chim Acta. 1050:113–122.
   PubMed Web of Science ®Google Scholar
• Huan T, Li L. 2015a. Counting missing values in a metabolite-intensity data set for measuring the analytical performance of a metabolomics platform. Anal Chem. 87(2):1306–1313.
   PubMed Web of Science ®Google Scholar
• Huan T, Li L. 2015b. Quantitative metabolome analysis based on chromatographic peak reconstruction in chemical isotope labeling liquid chromatography mass spectrometry. Anal Chem. 87(14):7011–7016.
   PubMed Web of Science ®Google Scholar
• Huan T, Troyer DA, Li L. 2016. Metabolite analysis and histology on the exact same tissue: comprehensive metabolomic profiling and metabolic classification of prostate cancer. Sci Rep. 6:32272.
   PubMed Web of Science ®Google Scholar
• Kaufman J, Birmaher B, Brent D, Rao U, Flynn C, Moreci P, Williamson D, Ryan N. 1997. Schedule for affective disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): initial reliability and validity data. J Am Acad Child Adolesc Psychiatry. 36(7):980–988.
   PubMed Web of Science ®Google Scholar
• Kurul S, Cakmakci H, Dirik E. 2004. Glutaric aciduria type 1: proton magnetic resonance spectroscopy findings. Pediatr Neurol. 31(3):228–231.
   PubMed Web of Science ®Google Scholar
• Lee CC, Hsieh YJ, Chen SW, Fu SH, Hsu CW, Wu CC, Han W, Li Y, Huan T, Chang YS, et al. 2018. Bretschneider solution-induced alterations in the urine metabolome in cardiac surgery patients. Sci Rep. 8(1):17774.
   PubMed Web of Science ®Google Scholar
• Lee CJ, Wu CC, Chou WJ, Lee MJ, Chou MC, Lee SY, Wang LJ. 2019. Mitochondrial-associated protein biomarkers in patients with attention-deficit/hyperactivity disorder. Mitochondrion. 49:83–88.
   PubMed Web of Science ®Google Scholar
• Li L, Li R, Zhou J, Zuniga A, Stanislaus AE, Wu Y, Huan T, Zheng J, Shi Y, Wishart DS, et al. 2013. MyCompoundID: using an evidence-based metabolome library for metabolite identification. Anal Chem. 85(6):3401–3408.
   PubMed Web of Science ®Google Scholar
• Mahone EM, Denckla MB. 2017. Attention-deficit/hyperactivity disorder: a historical neuropsychological perspective. J Int Neuropsychol Soc. 23(9-10):916–929.
   PubMed Web of Science ®Google Scholar
• Peng J, St Laurent CD, Befus AD, Zhou RK, Li L. 2014. Metabolomic profiling of bronchoalveolar lavage fluids by isotope labeling liquid chromatography mass spectrometry: a promising approach to studying experimental asthma. Metabolomics. 10(6):1305–1317.
   Web of Science ®Google Scholar
• Puurunen J, Sulkama S, Tiira K, Araujo C, Lehtonen M, Hanhineva K, Lohi H. 2016. A non-targeted metabolite profiling pilot study suggests that tryptophan and lipid metabolisms are linked with ADHD-like behaviours in dogs. Behav Brain Funct. 12(1):27.
   PubMed Web of Science ®Google Scholar
• Radha Rama Devi A, Ramesh VA, Nagarajaram HA, Satish SP, Jayanthi U, Lingappa L. 2016. Spectrum of mutations in Glutaryl-CoA dehydrogenase gene in glutaric aciduria type I–Study from South India. Brain Dev. 38(1):54–60.
   PubMed Web of Science ®Google Scholar
• Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, Smyth GK. 2015. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43(7):e47.
   PubMed Web of Science ®Google Scholar
• Sayal K, Prasad V, Daley D, Ford T, Coghill D. 2018. ADHD in children and young people: prevalence, care pathways, and service provision. Lancet Psychiatry. 5(2):175–186.
   PubMed Web of Science ®Google Scholar
• Sorokina AM, Saul M, Goncalves TM, Gogola JV, Majdak P, Rodriguez-Zas SL, Rhodes JS. 2018. Striatal transcriptome of a mouse model of ADHD reveals a pattern of synaptic remodeling. PLoS One. 13(8):e0201553.
   PubMed Web of Science ®Google Scholar
• Sterley TL, Howells FM, Dimatelis JJ, Russell VA. 2016. Genetic predisposition and early life experience interact to determine glutamate transporter (GLT1) and solute carrier family 12 member 5 (KCC2) levels in rat hippocampus. Metab Brain Dis. 31(1):169–182.
   PubMed Web of Science ®Google Scholar
• Storey JD, Tibshirani R. 2003. Statistical significance for genomewide studies. Proc Natl Acad Sci USA. 100(16):9440–9445.
   PubMed Web of Science ®Google Scholar
• Thomas R, Sanders S, Doust J, Beller E, Glasziou P. 2015. Prevalence of attention-deficit/hyperactivity disorder: a systematic review and meta-analysis. Pediatrics. 135(4):e994–e1001.
   PubMed Web of Science ®Google Scholar
• Uddin LQ, Dajani DR, Voorhies W, Bednarz H, Kana RK. 2017. Progress and roadblocks in the search for brain-based biomarkers of autism and attention-deficit/hyperactivity disorder. Transl Psychiatry. 7(8):e1218.
   PubMed Web of Science ®Google Scholar
• Wang LJ, Wu CC, Lee Mj, Chou Mc, Lee Sy, Chou Wj 2019. Peripheral brain-derived neurotrophic factor and contactin-1 levels in patients with attention-deficit/hyperactivity disorder. J Clin Med. 8:pii:E1366.
   Web of Science ®Google Scholar
• Watson SD. 2003. Wechsler Intelligence Scale for Children, 4th ed. San Antonia (TX): PsychCorp.
   Google Scholar
• Womersley JS, Dimatelis JJ, Russell VA. 2015. Proteomic analysis of maternal separation-induced striatal changes in a rat model of ADHD: The spontaneously hypertensive rat. J Neurosci Methods. 252:64–74.
   PubMed Web of Science ®Google Scholar
• Xu W, Chen D, Wang N, Zhang T, Zhou R, Huan T, Lu Y, Su X, Xie Q, Li L, et al. 2015. Development of high-performance chemical isotope labeling LC-MS for profiling the human fecal metabolome. Anal Chem. 87(2):829–836.
   PubMed Web of Science ®Google Scholar
• Yang J, Yan B, Zhao B, Fan Y, He X, Yang L, Ma Q, Zheng J, Wang W, Bai L, et al. 2020. Assessing the causal effects of human serum metabolites on 5 major psychiatric disorders. Schizophr Bull. sbz138. DOI:10.1093/schbul/sbz138.
   PubMed Web of Science ®Google Scholar
• Zheng J, Dixon RA, Li L. 2012. Development of isotope labeling LC-MS for human salivary metabolomics and application to profiling metabolome changes associated with mild cognitive impairment. Anal Chem. 84(24):10802–10811.
   PubMed Web of Science ®Google Scholar